Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism RAMP2 modulators(Receptor activity modifying protein 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinopathy of Prematurity | Preclinical | JP | 15 Dec 2023 | |
Neoplasms | Preclinical | JP | - |